Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AX03	METOJECT	G	Methotrexate disodium - 15mg/0.3ml	15mg/0.3ml	Injectable solution	1,968,729 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 20mg/0.4ml	20mg/0.4ml	Injectable solution	2,134,022 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 25mg/0.5ml	25mg/0.5ml	Injectable solution	2,582,865 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	15,102,158 L.L
L04AA42	MAYZENT	B	Siponimod - 0.25mg	0.25mg	Tablet, film coated	124,258,444 L.L
L04AA42	MAYZENT	B	Siponimod - 2mg	2mg	Tablet, film coated	124,258,444 L.L
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	18,723,042 L.L
L04AA06	MMF	G	Mycophenolate mofetil - 500mg	500mg	Tablet, coated	4,087,969 L.L
L03AX16	MOZOBIL	B	Plerixafor - 20mg/ml	20mg/ml	Injectable solution	413,801,327 L.L
L01FX02	MYLOTARG	BioTech	Gemtuzumab Ozogamicin - 4.5mg	4.5mg	Injectable powder	807,679,884 L.L
L01FG01	MVASI	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	58,035,926 L.L
L01FG01	MVASI	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	17,173,671 L.L
L01FD01	MABTIN 440	BioTech	Trastuzumab (r-DNA origin) - 440mg	440mg	Injectable powder for solution	70,042,700 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	22,183,393 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	11,091,696 L.L
L01FA01	MABTHERA	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	35,722,424 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	136,761,210 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	74,718,320 L.L
L01FA01	MABTHERA	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	80,211,932 L.L
L01EB02	MIRATA	G	Erlotinib (HCl) - 100mg	100mg	Tablet, film coated	77,485,888 L.L
L01EB02	MIRATA	G	Erlotinib (HCl) - 150mg	150mg	Tablet, film coated	88,722,301 L.L
L01DB07	MITOXANTRON EBEWE	G	Mitoxantrone - 20mg/10ml	20mg/10ml	Injectable concentrated solution	11,064,120 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	186,970,904 L.L
L01BA01	METHOTREXAT EBEWE	G	Methotrexate - 500mg	500mg	Injectable solution	1,842,408 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L
J07BD52	MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR	G	Rubella virus live attenuated - =1000CCID50 /0.5ml, Mumps virus live attenuated - =5000CCID50 /0.5ml, Measles virus live attenuated - =1000CCID50 /0.5ml		Injectable freeze dried powder + diluent	739,113 L.L
J07AH08	MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE	B	Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml		Injectable solution	6,144,048 L.L
J07AH08	MENQUADFI	G	Meningococcal (serogroups A, C, W and Y) conjugate vaccine -		Injectable solution	4,859,334 L.L
J07AH	MENFIVE	G	Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine -		Injectable freeze dried powder + diluent	3,527,587 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L

...